Erik E L Jansen

9PUBLICATIONS
18CO-AUTHORS
Epidemiological methodsPsychosocial aspects of childbirth and perinatal mental healthCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 09, 2025
Under which realistic circumstances is hrHPV self-sampling increasing cervical screening effectiveness in a partly vaccinated population? A modelling study.

Sylvia Kaljouw, Erik E L Jansen, Ellen M G Olthof

|Apr 28, 2025
Should the age range of the Dutch hrHPV-based cervical cancer screening program be broadened? A modelling study using cohort effects.

Sylvia Kaljouw, Erik E L Jansen, Veerle J C Schevenhoven

|Apr 22, 2025
Optimizing the Harms and Benefits of Cervical Screening in a Partially Vaccinated Population in Ontario, Canada: A Modeling Study.

Daniël D de Bondt, Erik E L Jansen, Christine Stogios

|Nov 10, 2022
Rapid elimination of cervical cancer while maintaining the harms and benefits ratio of cervical cancer screening: a modelling study.

Erik E L Jansen, Inge M C M de Kok, Sylvia Kaljouw

|Oct 12, 2022
A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions.

Emily A Burger, Inge M C M de Kok, James F O'Mahony

|Apr 16, 2022
Shift in harms and benefits of cervical cancer screening in the era of HPV screening and vaccination: a modelling study.

Sylvia Kaljouw, Erik E L Jansen, Clare A Aitken

Pageof 2

Frequent Collaborators

6 joint publications

Inge M C M de Kok

4 joint publications

Sylvia Kaljouw

3 joint publications

Clare A Aitken

2 joint publications

Jan A C Hontelez